There were 940 press releases posted in the last 24 hours and 428,295 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image